Companies: 10,795·Total market cap: $144.5T
Humacyte, Inc.

Humacyte, Inc.

HUMANASDAQHealthcare● Active
$1.38
+$0.03(+2.22%)
Market Cap$231840000
P/E Ratio
52W High$2.93
52W Low$0.547
Overview

Humacyte, Inc.(HUMA)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · HUMA · 截至 2026-06-08

财务报表

Revenue · Gross Profit · Net Income
Breakdown2025-122024-122023-122022-122021-12
Revenue
Revenue$2.04M$0.00M$0.00M$1.56M$1.26M
Cost of Revenue$17.05M$7.19M$76.55M$8.26M$61.34M
Gross Profit($15.01M)($7.19M)($76.55M)($6.69M)($60.08M)
Gross Margin %(computed)-736.46%-427.48%
Operating Expenses
R&D Expenses$69.30M$88.60M$76.55M$63.26M$61.34M
G&A Expenses$31.17M$25.80M$23.39M$22.88M$21.02M
Total Operating Expenses$92.43M$107.21M$23.50M$77.89M$21.13M
Operating Income($107.44M)($114.40M)($100.05M)($84.58M)($81.21M)
Operating Margin %(computed)
Interest Income$2.59M$4.10M$5.47M$2.63M$0.02M
Interest Expense$11.25M$9.28M$6.60M$6.20M$4.35M
Income Before Tax($40.83M)($148.70M)($110.78M)($11.96M)($26.48M)
Income Tax Expense$0.00M$0.00M$0.00M$0.00M$0.00M
Net Income($40.83M)($148.70M)($110.78M)($11.96M)($26.48M)
Net Margin %(computed)-764.54%
Per Share & EBITDA
EPS (Basic)$-0.26$-1.26$-1.07$-0.12$-0.66
Wtd Avg Shares158.16M118.48M103.42M103.05M39.97M
EBITDA($100.09M)($132.23M)($96.46M)($76.37M)($72.97M)
EBITDA Margin %(computed)

数据来源:Financial Modeling Prep · 最后更新:2026-06-08 · USD · M

深入了解Humacyte, Inc.

关于Humacyte, Inc.(HUMA)损益表

Humacyte, Inc.(HUMA)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,HUMA实现营收$0.00B,毛利润($0.02B)(毛利率-736.46%),净利润($0.04B)(净利率-2003.58%)。

常见问题

HUMA · 4 问

Humacyte, Inc.(HUMA)2025财年营收为$0.00B,同比up—%。

HUMA revenueHUMA salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08